Rolling Stone | December 22, 2021
Now it’s even worse — and even less forgivable. “We’re doing very badly,” Lawrence Gostin, a Georgetown University global-health expert, tells Rolling Stone. Too few Americans are getting tested. Sequencing labs need more, and more stable, funding. A dearth of samples and cash mean we don’t have a clear picture of a fast-changing pandemic. We don’t know what we’re dealing with today. We don’t know what to expect tomorrow.